Key result
Pharmacy-driven bedside discharge medication delivery was not independently associated with a reduction in day 30 hospital readmissions compared to usual care (adjusted OR 0.91; 95% CI 0.79-1.04; P=0.17).
Why the study?
Transitions of care bundles including bedside discharge medication delivery may decrease hospital readmissions, but the effect of bedside delivery alone remained unclear.
Does pharmacy-driven bedside discharge medication delivery reduce day 30 hospital readmission in hospitalized patients?
Population
30916 hospitalized patients meeting inclusion and exclusion criteria
Comparison
Pharmacy-driven BDMD vs usual discharge
Design
Retrospective cohort study
Follow-up
Day 30
Authors
Loading...
No support for routine bedside pharmacy discharge programs to cut readmissions; leaves open need for randomized confirmation.
Cohort (n=30,916)
Does pharmacy-driven bedside discharge medication delivery reduce day 30 hospital readmission in hospitalized patients?
Odds Ratio: 0.91 (95% CI 0.79–1.04)
Absolute Event Rate: 10.6% vs 12.8%
p-value: p=0.17
A pharmacy-driven bedside discharge medication delivery program was not independently associated with a reduction in 30-day hospital readmissions after adjusting for baseline characteristics.
Lam et al. (2019) reported a cohort. Pharmacy-driven bedside discharge medication delivery (BDMD) vs. Usual care was evaluated on Day 30 readmission rates (adjusted OR 0.91, 95% CI 0.79-1.04, p=0.17). Pharmacy-driven bedside discharge medication delivery was not independently associated with a reduction in day 30 hospital readmissions compared to usual care (adjusted OR 0.91; 95% CI 0.79-1.04; P=0.17).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: